HUP0202652A2 - Pharmaceutical carrier composition - Google Patents

Pharmaceutical carrier composition

Info

Publication number
HUP0202652A2
HUP0202652A2 HU0202652A HUP0202652A HUP0202652A2 HU P0202652 A2 HUP0202652 A2 HU P0202652A2 HU 0202652 A HU0202652 A HU 0202652A HU P0202652 A HUP0202652 A HU P0202652A HU P0202652 A2 HUP0202652 A2 HU P0202652A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical carrier
carrier composition
composition
pharmaceutical
carrier
Prior art date
Application number
HU0202652A
Other languages
Hungarian (hu)
Inventor
Mahdi Bakir Fawzi
Richard William Saunders
Joseph Kyuwung Yoon
Original Assignee
American Cyanamid Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co. filed Critical American Cyanamid Co.
Publication of HUP0202652A2 publication Critical patent/HUP0202652A2/en
Publication of HUP0202652A3 publication Critical patent/HUP0202652A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
HU0202652A 1999-09-27 2000-09-26 Pharmaceutical carrier composition HUP0202652A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40616499A 1999-09-27 1999-09-27
PCT/US2000/026381 WO2001022942A1 (en) 1999-09-27 2000-09-26 Pharmaceutical carrier formulation

Publications (2)

Publication Number Publication Date
HUP0202652A2 true HUP0202652A2 (en) 2004-05-28
HUP0202652A3 HUP0202652A3 (en) 2004-06-28

Family

ID=23606801

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202652A HUP0202652A3 (en) 1999-09-27 2000-09-26 Pharmaceutical carrier composition

Country Status (18)

Country Link
EP (1) EP1216029A1 (en)
JP (1) JP2003510267A (en)
KR (1) KR20020064289A (en)
CN (1) CN1399542A (en)
AR (1) AR025867A1 (en)
AU (1) AU7716100A (en)
BR (1) BR0014308A (en)
CA (1) CA2388471A1 (en)
CZ (1) CZ20021082A3 (en)
EA (1) EA200200415A1 (en)
HK (1) HK1044485A1 (en)
HU (1) HUP0202652A3 (en)
IL (1) IL148543A0 (en)
MX (1) MXPA02003190A (en)
NO (1) NO20021476L (en)
PL (1) PL354331A1 (en)
WO (1) WO2001022942A1 (en)
ZA (1) ZA200203311B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
JPWO2004073692A1 (en) * 2003-02-18 2006-06-01 山下 伸二 Hard capsule of poorly water-soluble drug
CN100342856C (en) * 2003-04-10 2007-10-17 上海医药工业研究院 Composition of danazol semisolid skeleton preparation
US8333989B2 (en) 2005-10-26 2012-12-18 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
CA2627351C (en) 2005-10-26 2012-05-01 Banner Pharmacaps, Inc. Lipophilic vehicle-based dual controlled release matrix system
EP2068829A2 (en) * 2006-10-31 2009-06-17 Wyeth Semi-solid formulations of phospholipase enzyme inhibitors
JP7268012B2 (en) 2017-12-20 2023-05-02 フイルメニツヒ ソシエテ アノニム oral care composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636123A1 (en) * 1986-10-23 1988-05-05 Rentschler Arzneimittel ORAL ADMINISTRATIVE PREPARATIONS CONTAINING SINGLE DOSE FROM 10 TO 240 MG DIHYDROPYRIDINE
WO1995022331A1 (en) * 1994-02-18 1995-08-24 Cephalon, Inc. Aqueous indolocarbazole solutions
WO1999036060A1 (en) * 1998-01-20 1999-07-22 Applied Analytical Industries, Inc. Oral liquid compositions

Also Published As

Publication number Publication date
CN1399542A (en) 2003-02-26
NO20021476D0 (en) 2002-03-25
HUP0202652A3 (en) 2004-06-28
ZA200203311B (en) 2003-12-31
MXPA02003190A (en) 2002-09-30
IL148543A0 (en) 2002-09-12
EP1216029A1 (en) 2002-06-26
AU7716100A (en) 2001-04-30
AR025867A1 (en) 2002-12-18
CA2388471A1 (en) 2001-04-05
CZ20021082A3 (en) 2002-06-12
HK1044485A1 (en) 2002-10-25
BR0014308A (en) 2002-05-21
NO20021476L (en) 2002-04-16
JP2003510267A (en) 2003-03-18
EA200200415A1 (en) 2002-10-31
KR20020064289A (en) 2002-08-07
WO2001022942A1 (en) 2001-04-05
PL354331A1 (en) 2004-01-12

Similar Documents

Publication Publication Date Title
PL351387A1 (en) Pharmaceutical composition
GB0028088D0 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
GB9923436D0 (en) Pharmaceutical compositions
PL351686A1 (en) Novel pharmaceutical
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
IL145632A0 (en) Pharmaceutical compounds
GB9904163D0 (en) Pharmaceutical compositions
EG23937A (en) Novel pharmaceutical
GB9916434D0 (en) Pharmaceutical compounds
GB9911017D0 (en) Pharmaceutical compositions
HUP0202652A3 (en) Pharmaceutical carrier composition
AU8832301A (en) Pharmaceutical composition having modified carrier
GB9909041D0 (en) Novel pharmaceutical
GB9914255D0 (en) Pharmaceutical compounds
GB9903784D0 (en) Pharmaceutical compounds
EG23946A (en) Novel pharmaceutical
GB9904911D0 (en) Pharmaceutical compositions
GB2373499B (en) Pharmaceutical compounds
GB9902651D0 (en) Pharmaceutical compositions
GB9923933D0 (en) Novel pharmaceutical
GB9923934D0 (en) Novel pharmaceutical
GB9916210D0 (en) Pharmaceutical composition
GB9916413D0 (en) Pharmaceutical composition
GB9908643D0 (en) Novel pharmaceutical composition